Program at a Glance of APAC 2019 & 2019 TSOC Winter ...

Program at a Glance of

APAC 2019 & 2019 TSOC Winter Scientific Meeting

November 23 (Saturday) November 24 (Sunday)

Venue Room A

(3F)

Venue Room A

(3F)

09:00

10:20

Thrombus Management

(P.1)

07:45

08:35

Meet the Master:

Acute Myocardial Infarction

10:30

10:50 Break

08:42

09:50

How to Manage Hemodynamically

Unstable Patients

(P.6)

11:00

12:20

Pre-Hospital and Primary PCI Care

(P.2)

10:00

10:20 Break

12:30

13:50

Luncheon Symposium

(Intracoronary Imaging)

(P.3)

10:30

11:50

How to Manage Complications in

Primary PCI

(P.7)

14:00

15:20

Strategies in Primary PCI

(P.4)

12:00

13:20

TSOC Luncheon Symposium

[Menarini]

15:30

15:50 Break

16:00

17:20

Challenging Cases in AMI

(P.5)

17:30

18:50

TSOC Evening Symposium

[Daiichi Sankyo]

19:00

21:00

APAC Faculty Dinner

(Junior Ballroom, 5F)

Only by Invitation

November 23 (Saturday)

Venue Room B+C

(3F)

Room D

(3F)

Room E

(3F)

09:00

10:20

Transcatheter VSD Closure: How I Do It?

(P.9)

Imaging the Hypertrophic Left Ventricles

(P.11)

Perspectives on Hypertension Management

in 2020 (I) (P.13)

10:30

10:50 Break

11:00

12:20

Left Atrium in 2020 (P.10)

Team-Based Care Approach in Cardiovascular

Prevention (P.12)

Perspectives on Hypertension Management

in 2020 (II) (P.14)

12:30

13:50

Luncheon Symposium

[AstraZeneca]

Luncheon Symposium

[Amgen]

Luncheon Symposium

[Novartis]

14:00

15:20

Heart Failure with Preserved Ejection Fraction

(HFpEF) Symposium (P.15)

2019 Ventricular Arrhythmia Ablation Guidelines Update

(P.17)

Management of Diabetes in Patients with CVD:

Where Do We Stand in 2019?

(I) (P.19)

15:30

15:50 Break

16:00

17:20

Special Lecture & Heart Failure Abstract

Competition (P.16)

Lesson Learned From Complications of EP

Procedures (P.18)

Management of Diabetes in Patients with CVD:

Where Do We Stand in 2019?

(II) (P.20)

17:30

18:50

Evening Symposium

[Pfizer]

Evening Symposium

[Boehringer-Ingelheim]

November 24 (Sunday)

Venue Room B+C

(3F)

Room D

(3F)

Room E

(3F)

08:30

09:50

Interventional Cardiology: Coronary Perspectives

(P.21)

Structural Heart Diseases (P.23)

Mathematical Models in Cardiovascular Research

(P.25)

10:00

10:20 Break

10:30

11:50

Interventional Cardiology: Vascular Perspectives

(P.22)

TSOC-*NCHCPF Joint Session:

Precision Medicine (P.24)

Pulmonary Arterial Hypertension Symposium

(P.26)

12:00

13:20

Luncheon Symposium

[AstraZeneca]

2019年亞洲緊急冠狀動脈介入治療會議

會議議程

Agenda for Asia Primary Angioplasty

Congress 2019

1

11月23日〈星期六〉09 :00 -10 :20 SATURDAY, NOVEMBER 23 , 2019

台北萬豪酒店 3 樓博覽廳 A 室

Room A, 3F, Taipei Marriott Hotel, Taipei

THROMBUS MANAGEMENT

09:00 Opening Remarks ....................................................... Juey-Jen Hwang (Taiwan)

Chairs: Juey-Jen Hwang(Taiwan), Paul Ong(Singapore)

Panelists: Cheng-Chung Cheng(Taiwan), Chun-Chi Chen(Taiwan)

Tien-Yu Wu(Taiwan), Kirti Punamiya (India)

09:05 Device Versus Drug-Based Approach for

Thrombus Management .............................................. Chi-Hung Huang (Taiwan)

09:17 Nightmare at Midnight, Endless Thrombus in

Primary PCI......................................................................Wei-Shin Liu (Taiwan)

09:29 How to Treat Patient with Huge Thrombus Burden ....... Chung-Chi Yang (Taiwan)

09:41 The Solitaire Device in Acute Coronary

Syndrome ...................................................... Deanna Zhi-Lin Khoo (Singapore)

09:53 Thrombus Management ................................................... Feng-Yu Kuo (Taiwan)

10:05 My Strategies for Management of Coronary Thrombus During

STEMI PCI and Non STEMI PCI ........................................ Kirti Punamiya (India)

10:17 Discussion & Take-Home Message

2




PRE-HOSPITAL AND PRIMARY PCI CARE

Chairs: Wei-Chun Huang(Taiwan), Hee Hwa Ho(Singapore)

Panelists: Wei-Kung Tseng(Taiwan), Ching-Chang Fang (Taiwan)

Alan Fong (Malaysia), Saurabh Rastogi(Singapore)

11:00 Primary PCI – Where Are We In 2019? ....................... Sameer Mehta (U.S.A.)

11:12 AFRICA STEMI - A Snapshot ..................................... David Kettle (South Africa)

11:24 Pre-Hospital and Primary PCI in Hong Kong ............... Kin-Lam Tsui (Hong Kong)

11:36 Pre-Hospital and Primary PCI in Malaysia ........................... Alan Fong (Malaysia)

11:48 Feasibility of Primary PCI via Snuffbox Approach in

Patients with STEMI ....................................................... Yongcheol Kim (Korea)

12:00 Pre-Hospital and Primary PCI in Taiwan ..................... Wei-Chun Huang (Taiwan)


3

11月23日〈星期六〉12 :30-13 :50 SATURDAY, NOVEMBER 23 , 2019



LUNCHEON SYMPOSIUM:

INTRACORONARY IMAGING

Chairs: Jun-Jack Cheng(Taiwan), Sameer Mehta (U.S.A.)

Panelists: Tse-Min Lu(Taiwan), Chia-Pin Lin(Taiwan)

Jason Loh(Singapore), Yuji Ikari (Japan)

12:30 The Role of OCT in Acute Coronary Syndromes .................... Tom Johnson (U.K.)

12:42 Topic Related to iFR ..................................................... Tao-Cheng Wu (Taiwan)

12:54 Topic Related to FFR ........................................ Wasan Udayachalerm (Thailand)

13:06 OCT for ACS/AMI ─

Look Beyond the Angiogram ......................... Michael Kang-Yin Lee (Hong Kong)

13:18 IVUS Findings in ACS .............................................................. Yuji Ikari (Japan)

13:30 Case Sharing ............................................................. Jin-Hyun Lee (Singapore)


4




STRATEGIES IN PRIMARY PCI

Chairs: Tom Johnson(U.K.), Richard Ng(Singapore)

Panelists: Chi-Jen Chang(Taiwan), Po-Chao Hsu(Taiwan)

Asri Ranga (Malaysia), Soe Win Kyaw (Myanmar)

14:00 PCI Strategies of Multivessel STEMI:

- Infarct-Related Artery (IRA) Only or Treat Multivessels?

- The Timing of Complete Revascularization ................... Chun-Hung Su (Taiwan)

14:12 PCI Strategies in Patients with ST-Segment Elevation Myocardial

Infarction and Multivessel Coronary Artery

Disease...................................................................... Soe Win Kyaw (Myanmar)

14:24 For LM Intervention During Primary PCI: One Stent or Two

Stent Technique: Which is the Best Strategy? .......... Ching-Tang Chang (Taiwan)

14:36 For High Bleeding Risk Patients or Patients With Recent Necessity for

Surgical Intervention, How to Treat These Patients During Primary PCI

and What is the Current Evidence? ............................... Yu-Chen Wang (Taiwan)

14:48 Primary Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction

Network: Outcome & Determinant Factors. ........................Asri Ranga (Malaysia)

15:00 Risk Factors of Mortality and Heart Failure in Patients with Acute Myocardial

Infarction and Cardiogenic Shock Under ECMO Support: A Single Institute

Experience .................................................................. Chin-Sheng Lin (Taiwan)


5




CHALLENGING CASES IN AMI

Chairs: Yen-Wen Wu(Taiwan), Ronald Lee(Singapore)

Panelists: Chung-Ho Hsu(Taiwan), Shih-Chi Liu(Taiwan)

Quang Ngoc Nguyen (Vietnam), Jose Nicolas Cruz (Philippines)

16:00 AMI with LM Bifurcation Lesion ..................................... Jen-Kuang Lee (Taiwan)

16:10 Primary PCI for Ectatic LAD ........................................ Wen-Huang Lee (Taiwan)

16:20 STEMI in Ectatic Vessel with Large Thrombus Burden ... Chun-Yuan Chu (Taiwan)

16:30 AMI Involved in Myocardial Bridging .................... Quang Ngoc Nguyen (Vietnam)

16:40 Implementation of a Cardiogenic Shock Team and Clinical Outcomes:

Observational and Retrospective Study ....................... Ramesh Singh (Malaysia)

16:50 To Chase or Leave Behind A Distal Stent-Edge Dissection:

Preventing A Solution-Caused Problem ............... Jose Nicolas Cruz (Philippines)

17:00 Case Sharing ................................................................ Joshua Loh (Singapore)


6

1 1月2 4日〈星期日〉0 8 : 4 2 - 0 9 : 5 0 S U N D A Y , N O V E M B E R 2 4 , 2 0 1 9



HOW TO MANAGE HEMODYNAMICALLY UNSTABLE PATIENTS

Chairs: Chi-Ling Hung(Taiwan), Tien-Ping Tsao(Taiwan)

Panelists: Hsuan-Li Huang(Taiwan), Yueh-Chung Chen(Taiwan)

Nikolas Wanahita (Singapore), Fahim Haider Jafary (Singapore)

08:42 The Role of IABP and ECMO in Hemodynamically

Unstable AMI Patients: Pro ............................................... Hon-Kan Yip (Taiwan)

08:54 The Role of IABP and ECMO in Hemodynamically

Unstable AMI Patients: Con .......................................... Mu-Yang Hsieh (Taiwan)

09:06 Strategies in the Management of Hemodynamically

Unstable AMI Patients ................................................. Cheng-Han Lee (Taiwan)

09:18 Clincal Experience of PCPS in Hemodynamically

Unstable AMI Patient ....................................................... Wei-Ren Lan (Taiwan)

09:30 Experience Sharing ................................................ Chia Yew Woon (Singapore)


7




HOW TO MANAGE COMPLICATIONS IN PRIMARY PCI

Chairs: Wei-Hsian Yin(Taiwan), Michael Kang-Yin Lee (Hong Kong)

Panelists: Yi-Chih Wang(Taiwan), Cheng-Han Lee(Taiwan)

Seung-Woon Rha (Korea), Michael Liang(Singapore)

10:30 Acute Ischemic Stroke Developed During

Primary PCI................................................................... Tse-Wei Chen (Taiwan)

10:42 Perforated Iliac Artery in STEMI with

Cardiogenic Shock ...................................................... Ting-Jun Huang (Taiwan)

10:54 No Reflow During Primary PCI ............................... Cheng-Chung Hung (Taiwan)

11:06 Primary PCI for Anterior STEMI Complicated with

Aortic Dissection ........................................................... Shang-Yeh Lu (Taiwan)

11:18 Management of Slow Flow/No Reflow During

Primary PCI................................................................ Seung-Woon Rha (Korea)

11:30 Case Sharing ............................................................ Michael Liang (Singapore)

11:42 Discussion

11:48 Closing Remarks ....................... Wei-Hsian Yin (Taiwan) & Paul Ong (Singapore)

8

中華民國心臟學會

2019 年冬季學術研討會

議程

9


台北萬豪酒店 3 樓博覽廳 B+C 室

Room B+C, 3F, Taipei Marriott Hotel, Taipei

TRANSCATHETER VSD CLOSURE: HOW I DO IT?

Chairs: 吳美環(Mei-Hwan Wu)、吳俊明(Jing-Ming Wu)

09:00 Match The Device to The Morphology of VSD: How to Select Device?.......王主科

(Jou-Kou Wang)

09:15 How to Avoid Complications in VSD Closure…………………………..………鍾宏濤

(Hung-Tao Chung)

09:30 Outlet Type VSD Closure (ADOI) ........................................................... 徐宗正

(Tsung-Cheng Shyu)

09:45 Outlet Type VSD Closure (ADOII) .......................................................... 林杏佳

(Hsin-Chia Lin)

10:00 My Nightmare Case .............................................................................. 林銘泰

(Ming-Tai Lin)

10:15 Panel Discussion

10




LEFT ATRIUM IN 2020

11:00 Opening Remarks…………………...........................................................蔡建松

(Chien-Sung Tsai)

Chairs: 蔡峰鈞(Feng-Chun Tsai)、宋思賢(Shih-Hsien Sung)

11:02 Mitral Therapy in New Era (Surgery)..........................................................陳怡誠

(I-Chen Chen)

11:17 Mitral Therapy in New Era (Medicine)………………….………………..………李慶威

(Ching-Wei Lee)

11:32 Commentators: 鄭伯智(Bor-Chih Cheng)、鄭錦昌(Chin-Chang Cheng)

11:38 Discussion

Chairs: 許榮彬(Ron-Bin Hsu)、林彥璋(Yenn-Jiang Lin)

11:42 AF Treatment in 2020 (Surgery) ............................................................ 紀乃新

(Nai-Hsin Chi)

11:57 AF Treatment in 2020 (Medicine)........................................................... 林維祥

(Wei-Shiang Lin)

12:12 Commentators: 張仁平(Jen-Ping Chang)、葉勇信(Yung-Hsin Yeh)

12:18 Discussion

12:22 Closing Remarks……………………...........................................................許榮彬

(Ron-Bin Hsu)

11


台北萬豪酒店 3 樓春夏廳

Room D, 3F, Taipei Marriott Hotel, Taipei

IMAGING THE HYPERTROPHIC LEFT VENTRICLES

Chair: 秦志輝(Chih-Hui Chin)

09:00 Echocardiographic Examinations for the Differential Diagnosis and

Classification…………………………………………………….........................余文鍾

(Wen-Chung Yu)

09:25 Imaging Diagnosis by Magnetic Resonance Imaging and Computed

Tomography.……..…………………………………………………………………洪崇烈

(Chung-Lieh Hung)

09:50 Peri-interventional Echocardiography for the Hypertrophic

Cardiomyopathy...…………………………………………………………………..林隆君

(Lung-Chun Lin)

10:15 Discussion and Closing Remarks………………………………………………..秦志輝

(Chih-Hui Chin)

12




TEAM-BASED CARE APPROACH IN CARDIOVASCULAR

PREVENTION

Chair:林宗憲(Tsung-Hsien Lin)

11:00 ASCVD: FEMH……..…………………………………………...........................吳彥雯

(Yen-Wen Wu)

11:25 AF/Arrhythmia: VGH……..……..…………………………………………………林彥璋

(Yenn-Jiang Lin)

11:50 Heart Failure: CGMH...…………………………………………………………..謝宜璋

(I-Chang Hsieh)

12:15 Discussion and Closing Remarks………………………………………………林宗憲

(Tsung-Hsien Lin)

13


台北萬豪酒店 3 樓秋冬廳

Room E, 3F, Taipei Marriott Hotel, Taipei

PERSPECTIVES ON HYPERTENSION MANAGEMENT IN 2020 (I)

09:00 Opening Remarks ................................................................................. 林幸榮

(Shing-Jong Lin)

Chair: 林幸榮(Shing-Jong Lin)

09:05 Ambulatory BP Monitoring: Roles in Diagnosis and Management ............ 鄭浩民

(Hao-Min Cheng)

Chair: 賴文德(Wen-Ter Lai)

09:25 Home BP Monitoring: Current Status and Consensus ............................. 林鴻儒

(Hung-Ju Lin)

09:45 Central BP and Arterial Physiology: Clinical Implications ........................ 陳震寰

(Chen-Huan Chen)

Chair: 程文俊(Wen-Jin Cherng)


10:15 Closing Remarks .................................................................................. 程文俊

(Wen-Jin Cherng)

14




PERSPECTIVES ON HYPERTENSION MANAGEMENT IN 2020 (II)

11:00 Opening Remarks ................................................................................ .陳文鍾

(Wen-Jone Chen)

Chair: 江晨恩(Chern-En Chiang)

11:05 Should Patients With AHA Stage 1 Hypertension (130-139/80-89 mmHg)

Be Treated With Antihypertensive Pharmacological Therapy?

If Yes, Whom Should Be Treated? ......................................................... 翁國昌

(Kwo-Chang Ueng)

Chair: 鄭書孟(Shu-Meng Cheng)

11:30 Should Initial Combination Therapy Strategy Be Applied to

All Hypertensive Patients? .................................................................... 陳宗瀛

(Chung-Yin Chen)

Chair: 王國陽(Kuo-Yang Wang)

11:55 Should the BP Goal of Elderly Patients Be Reduced to

<130/80 mmHg? ................................................................................... 陳郁志

(Michael Yu-Chih Chen)

Chair: 林中生(Chung-Sheng Lin)


12:17 Closing Remarks .................................................................................. 林中生

(Chung-Sheng Lin)

15




HEART FAILURE WITH PRESERVED EJECTION FRACTION

(HFpEF) SYMPOSIUM

Chair: 張坤正(Kuan-Cheng Chang)

14:00 Role of ACEIs/ARBs and ARNI in the Treatment of HFpEF..... John J.V. McMurray

Chair: 林維祥(Wei-Shiang Lin)

14:25 Role of Beta-Blockers in the Treatment of HFpEF.……..………Giuseppe Ambrosio

Chair: 黃金隆(Jin-Long Huang)

14:50 Role of Mineralocorticoid Receptor Antagonists in the

Treatment of HFpEF………….…………………………………………………..洪崇烈

(Chung-Lieh Hung)

Chair: 李啟明(Chii-Ming Lee)

15:10 Q & A

16




SPECIAL LECTURE & HEART FAILURE ABSTRACT

COMPETITION

Chair: 黃瑞仁(Juey-Jen Hwang)

16:00 New Perspectives and Future Directions in the Treatment of Heart

Failure………………………………………….…………….... John J.V. McMurray

心衰竭論文摘要競賽

HEART FAILURE ABSTRACT COMPETITION

Referees:

16:25

17




2019 VENTRICULAR ARRHYTHMIA ABLATION GUIDELINES

UPDATE

14:00 Opening Remarks…………………………………………..……..…….............吳茲睿

(Tsu-Juey Wu)

Chairs:

林彥璋(Yenn-Jiang Lin)、謝敏雄(Ming-Hsiung Hsieh)、林亮宇(Lian-Yu Lin)

14:02 Localization of Ventricular Arrhythmia by Surface ECG……..…….............祁栢慶

(Po-Ching Chi)

14:14 Idiopathic Ventricular Arrhythmia (VT/VPC), Medical Therapy or

Ablation?…...............................................................................................陳威達

(Wei-Ta Chen)

14:26 How to Ablate VT in Patients with Structural Heart Disease………………..鐘法博

(Fa-Po Chung)

14:38 Diagnosis and Ablation of Fascicle Related VT (BBRVT

and Fascicular VT)……………….…..……………………………….................游治節

(Chih-Chieh Yu)

14:50 When and How to Perform Epicardial Ablation…….…………………………林晉宇

(Chin-Yu Lin)

15:02 Diagnosis, Risk Stratification, and Treatment (Including Ablation) of

ARVC...……………………………………………………………………………..廖英傑

(Ying-Chieh Liao)

Chair:溫明賢(Ming-Shien Wen)


15:18 Closing Remarks...……………………………………………………….………溫明賢

(Ming-Shien Wen)

18




LESSON LEARNED FROM COMPLICATIONS OF EP PROCEDURES

16:00 Opening Remarks…………………………………………..……..…….............劉言彬

(Yen-Bin Liu)

Chair:張坤正(Kuan-Cheng Chang)

16:02 Unexpected Complications After RVOT PVC Ablation……..…….............林圀宏

(Kuo-Hung Lin)

Chair:陳勉成(Mien-Cheng Chen)

16:14 Complications after AF Ablation...............................................................陳永隆

(Yung-Lung Chen)

Chair:郭任遠(Jen-Yuan Kuo)

16:26 Complications from AF Ablation & PPM Implant………………….…………..張盛雄

(Sheng-Hsiung Chang)

Chair:邱春旺(Chuen-Wang Chiou)

16:38 Complication After Trans-septal Procedure………………............................馮安寧

(An-Ning Feng)

Chair:謝育整(Yu-Cheng Hsieh)

16:50 Complication During Trans-septal Procedure & During LVOT Ablation……李政鴻

(Cheng-Hung Li)

Chair:林彥璋(Yenn-Jiang Lin)

17:02 Complication Cases Sharing..…………………………………………………..林晉宇

(Chin-Yu Lin)

Chair:林彥璋(Yenn-Jiang Lin)


17:22 Closing Remarks…………………………………………..……..…….............林彥璋

(Yenn-Jiang Lin)

19




MANAGEMENT OF DIABETES IN PATIENTS WITH CVD:

WHERE DO WE STAND IN 2019? (I)

14:00 Opening Remarks…………………………………………………………………..黃瑞仁

(Juey-Jen Hwang)

Chair: 褚柏顯(Pao-Hsien Chu)

14:05 SGLT-2 Inhibitor vs. GLP-1 RA: Who is The Winner?................................王岡陵

(Kang-Ling Wang)

Chair: 葉宏一(Hung-I Yeh)

14:30 Management of Diabetes in Patients with CV Risk Factors Alone.……….吳懿哲

(Yih-Jer Wu)

Chair: 劉秉彥(Ping-Yen Liu)

14:55 Management of Diabetes in Patients with Coronary Heart Disease..……..翁國昌

(Kwo-Chang Ueng)

Chair: 江福田(Fu-Tien Chiang)

15:20 Discussion

15:25 Closing Remarks…………………………………………………………………..林幸榮

(Shing-Jong Lin)

20




MANAGEMENT OF DIABETES IN PATIENTS WITH CVD:

WHERE DO WE STAND IN 2019? (II)

16:00 Opening Remarks…………………………………………………………………..陳文鍾

(Wen-Jone Chen)

Chair: 陳文鍾(Wen-Jone Chen)

16:05 Management of Diabetes in Patients with A History of Stroke....................王宇澄

(Yu-Chen Wang)

Chair: 鄭正一(Cheng-I Cheng)

16:30 Management of Diabetes in Patients with Chronic Kidney Disease.……….林宗憲

(Tsung-Hsien Lin)

Chair: 洪惠風(Huei-Fong Hung)

16:55 Management of Diabetes in Patients with Heart Failure……………….……..江晨恩

(Chern-En Chiang)

Chair: 賴文德(Wen-Ter Lai)

17:20 Discussion

17:25 Closing Remarks…………………………………………………………………..葉森洲

(San-Jou Yeh)

21




INTERVENTIONAL CARDIOLOGY: CORONARY PERSPECTIVES

08:30 Opening Remarks…………………………………………………………………..曹殿萍

(Tien-Ping Tsao)

Chair: 曹殿萍(Tien-Ping Tsao)

08:32 Current Application of New Oral Antiplatelets and Anticoagulants for

Coronary Artery Disease……………………………………………...................劉俊廷

(Jun-Ting Liou)

Chair: 蔡政廷(Cheng-Ting Tsai)

08:51 Clinical Significance of Physiological Assessment for LM and/or

Multivessel Disease……………………………………….……………………….吳道正

(Tao-Cheng Wu)

Chair: 盧澤民(Tse-Min Lu)

09:10 Rationale of Percutaneous Coronary Intervention for LM Disease ..………..張其任

(Chi-Jen Chang)

Chair: 王怡智(Yi-Chih Wang)

09:29 How to Manage LM Disease in Patients with Acute Coronary

Syndrome?…………………………………………………………………………..黃啟宏

(Chi-Hung Huang)

09:48 Closing Remarks…………………………………………………………………...王怡智

(Yi-Chih Wang)

22




INTERVENTIONAL CARDIOLOGY: VASCULAR PERSPECTIVES

10:30 Opening Remarks…………………………………………………………………..曹殿萍

(Tien-Ping Tsao)

Chair: 曹殿萍(Tien-Ping Tsao)

10:32 Antithrombotic Treatment for Symptomatic Peripheral Artery

Disease…………………………………………………….................................李貽恒

(Yi-Heng Li)

Chair: 曾維功(Wei-Kung Tseng)

10:51 Paclitaxel Eluting Devices in Endovascular Intervention:

Efficacy and Safety Issue Update…..…………………………………….…….李任光

(Jen-Kuang Lee)

Chair: 許栢超(Po-Chao Hsu)

11:10 The Armamentarium of Endovascular Intervention:

Fighting the Calcium in Peripheral Arterial Disease .……………………..…..徐中和

(Chung-Ho Hsu)

Chair: 陳俊吉(Chun-Chi Chen)

11:29 Beyond Revascularization, What Should We Know in CLI Patients?……..黃玄禮

(Hsuan-Li Huang)

11:48 Closing Remarks…………………………………………………………………...陳俊吉

(Chun-Chi Chen)

23



Room Spring & Summer, 3F, Taipei Marriott Hotel, Taipei

STRUCTURAL HEART DISEASES

Chairs:溫明賢(Ming-Shien Wen)、劉秉彥(Ping-Yen Liu)

08:30 LAA Closure vs. Anticoagulant in AF Patients………………………………...林廷澤

(Ting-Tse Lin)

08:45 What Device Available ? Watchman…………………………………..…….…羅秉漢

(Ping-Han Lo)

09:00 What Device Available ? Amulet………………………………………………. 朱俊源

(Chun-Yuan Chu)

09:15 Complications of LAA Closure ............................................................... 羅力瑋

(Li-Wei Lo)

09:30 What Device Available ?Lifetech LAA ................................................... 蔡佳醍

(Chia-Ti Tsai)


24



Room Spring&Summer, 3F, Taipei Marriott Hotel, Taipei

TSOC-*NCHCPF JOINT SESSION:

PRECISION MEDICINE

10:30 Opening Remarks ................................................................... 連文彬&連昭明

(Wen-Pin Lien & Jau-Min Lien)

Chair:陳錦澤(Jin-Jer Chen)

10:35 Precision Medicine for Cardiovascular Diseases Based on Genetic

Information………………………………………………………………...Toshihiro Tanaka

Chair:蔡佳醍(Chia-Ti Tsai)

11:15 Dosage Adjustment of Clopidogrel ......................................................... 李任光

(Jen-Kuang Lee)

Chair:柯毓麟(Yu-Lin Ko)

11:35 Reappraisal of Classical Anticoagulant, Warfarin in the Era of NOACs .... 溫明賢

(Ming-Shien Wen)

11:55 Closing Remarks .................................................................................. 陳錦澤

(Jin-Jer Chen)

*The New Century Health Care Promotion Foundation

25



Room Fall+Winter, 3F, Taipei Marriott Hotel, Taipei

MATHEMATICAL MODELS IN CARDIOVASCULAR RESEARCH

Chair: 蔡佳醍(Chia-Ti Tsai)

08:30 Cardiac Bidomain - 30 Years in Review…………………….........................林顯豐

(Shien-Fong Lin)

08:55 Spatial and Temporal Organization in Cardiac Fibrillation…………………羅孟宗

(Men-Tzung Lo)

Chair: 陳肇文(Jaw-Wen Chen)

09:20 Recent Development and applications of Real World Data (RWD)……………張新儀

(Hsing-Yi Chang)

09:45 Discussion and Closing Remarks..……………………………………………..陳肇文

(Jaw-Wen Chen)

26



Room Fall+Winter, 3F, Taipei Marriott Hotel, Taipei

PULMONARY ARTERIAL HYPERTENSION SYMPOSIUM

10:30 Opening Remarks…………………………………………………………………..黃偉春

(Wei-Chun Huang)

Chair: 林少琳(Shoa-Lin Lin)

10:35 Key Factors in Echo and Cath Examination of CTD-PAH Management.............許志新

(Chih-Hsin Hsu)

Chair: 吳懿哲(Yih-Jer Wu)

10:50 Unmet Need in Management of CTD-PAH Treatment…………………………….劉維新

(Wei-Shin Liu)

Chair: 雷孟桓(Meng-Huan Lei)

11:05 From Risk Assessment of Treatment Strategies for CTD-PAH Patient..………..邱昱偉

(Yu-Wei Chiu)

Chair: 吳俊逸(Chun-Yi Wu)

11:15 CTD-PAH Management Journey and Prospective: A Case Study (I)……..……..鄭錦昌

(Chin-Chang Cheng)

Chair: 賀萬靖(Wan-Jing Ho)

11:25 CTD-PAH Management Journey and Prospective: A Case Study (II) ............. 吳俊賢

(Chun-Hsien Wu)

Chair: 鄭書孟(Shu-Meng Cheng)


11:45 Closing Remarks…………………………………………………………………...鄭書孟

(Shu-Meng Cheng)

Program at a Glance of APAC 2019 & 2019 TSOC Winter ...

Documents

Transcript of Program at a Glance of APAC 2019 & 2019 TSOC Winter ...